Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    River-PCI
Show Display Options
Rank Status Study
1 Completed
Has Results
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Conditions: Coronary Artery Disease;   Angina Pectoris
Interventions: Drug: Ranolazine;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.